IHH Healthcare has announced a robust operational performance for the first quarter of 2025, with revenue increasing by 6% to RM6.3 billion. This growth is attributed to improved inpatient volumes and higher revenue intensity across several markets. The healthcare giant, which is on track to expand its capacity by 4,000 beds, added 1,000 beds last year.
The company reported a 17% rise in revenue and an 8% increase in EBITDA on a constant currency basis, showcasing its operational resilience despite challenges such as the full Ramadan holiday period affecting many markets. However, EBITDA saw a slight decline of 2% year-on-year due to higher finance costs from acquisitions and decreased contributions from Singapore, where renovations at Mount Elizabeth Hospital are underway.
Group CEO Prem Kumar Nair highlighted the company’s commitment to value-based care and its strategic growth priorities. “We reported resilient operational performance for Q1 2025, driven by an improvement in inpatient volumes and higher revenue intensity in some markets,” he stated. The company has embarked on a multi-year transformation plan focusing on clinical excellence, patient experience, and technological advancement to future-proof its business.
Despite a 33% drop in PATMI due to lower net monetary gains and deferred tax credits from the previous year, PATMI excluding exceptional items rose by 5%, reflecting core operational growth. IHH Healthcare also secured its first S$300 million sustainability-linked loan, reinforcing its dedication to sustainable practices.
Looking ahead, IHH Healthcare remains optimistic about its growth trajectory amid rising healthcare demands, focusing on profitability and sustainable returns on equity.
“`
